Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2005-09-01
Series:	PLoS Medicine
Online Access:	http://dx.doi.org/10.1371/journal.pmed.0020269

id	doaj-1f0720b7c6d247d1a4c8cd7407230ee2
record_format	Article
spelling	doaj-1f0720b7c6d247d1a4c8cd7407230ee22020-11-24T21:55:36ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762005-09-0129e269Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.http://dx.doi.org/10.1371/journal.pmed.0020269
collection	DOAJ
language	English
format	Article
sources	DOAJ
title	Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.
spellingShingle	Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R. PLoS Medicine
title_short	Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.
title_full	Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.
title_fullStr	Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.
title_full_unstemmed	Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.
title_sort	acquired gefitinib-resistant mutation of egfr in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation l858r.
publisher	Public Library of Science (PLoS)
series	PLoS Medicine
issn	1549-1277 1549-1676
publishDate	2005-09-01
url	http://dx.doi.org/10.1371/journal.pmed.0020269
_version_	1725861494711648256

Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.

Similar Items